Graft-Versus-Host Disease Amelioration by Human Bone Marrow Mesenchymal Stromal/Stem Cell-Derived Extracellular Vesicles Is Associated with Peripheral Preservation of Naive T Cell Populations. (27th December 2017)

• Record Type: Journal Article
• Authors: Fujii, Sumie; Miura, Yasuo; Fujishiro, Aya; Shindo, Takero; Shimazu, Yutaka; Hirai, Hideyo; Tahara, Hidetoshi; Takaori-Kondo, Akifumi; Ichinohe, Tatsuo; Maekawa, Taira
• Is Part Of: Stem cells. Volume 36:Number 3(2018)
• Page Start: 434
• Page End: 445
• Publication Date: 2017-12-27
• Subjects: Mesenchymal stem cells -- Graft-versus-host disease -- Extracellular vesicles -- microRNA -- Regulatory T cells -- Naive T cells -- Hematopoietic stem cell transplantation; Cloning -- Periodicals; Clone cells -- Periodicals; Stem cells -- Periodicals; Cell Differentiation -- Periodicals; Cell Division -- Periodicals; Clone Cells -- Periodicals; Hematopoietic Stem Cells -- Periodicals; Stem Cells -- Periodicals; 571.84
• DOI: 10.1002/stem.2759
• Languages: English
• ISSNs: 1066-5099

Abstract

Abstract : A substantial proportion of patients with acute graft-versus-host disease (aGVHD) respond to cell therapy with culture-expanded human bone marrow mesenchymal stromal/stem cells (BM-MSCs). However, the mechanisms by which these cells can ameliorate aGVHD-associated complications remain to be clarified. We show here that BM-MSC-derived extracellular vesicles (EVs) recapitulated the therapeutic effects of BM-MSCs against aGVHD. Systemic infusion of human BM-MSC-derived EVs prolonged the survival of mice with aGVHD and reduced the pathologic damage in multiple GVHD-targeted organs. In EV-treated GVHD mice, CD4+ and CD8+ T cells were suppressed. Importantly, the ratio of CD62L-CD44+ to CD62L + CD44- T cells was decreased, suggesting that BM-MSC-derived EVs suppressed the functional differentiation of T cells from a naive to an effector phenotype. BM-MSC-derived EVs also preserved CD4 + CD25 + Foxp3+ regulatory T cell populations. In a culture of CD3/CD28-stimulated human peripheral blood mononuclear cells with BM-MSC-derived EVs, CD3+ T cell activation was suppressed. However, these cells were not suppressed in cultures with EVs derived from normal human dermal fibroblasts (NHDFs). NHDF-derived EVs did not ameliorate the clinical or pathological characteristics of aGVHD in mice, suggesting an immunoregulatory function unique to BM-MSC-derived EVs. Microarray analysis of microRNAs in BM-MSC-derived EVs versus NHDF-derived EVs showed upregulation of miR-125a-3p and downregulation of cell proliferative processes, as identified by Gene Ontology enrichment analysis. Collectively, our findings provide the first evidence that amelioration of aGVHD by therapeutic infusion of BM-MSC-derived EVs is associated with the preservation of circulating naive T cells, possibly due to the unique microRNA profiles of BM-MSC-derived EVs. Abstract : Systemic infusion of human bone marrow mesenchymal stromal/stem cell (BM-MSC)-derived extracellular vesicles (EVs) prolongs the survival of mice with graft-versus-host disease (GVHD) and reduces the clinical symptoms and pathologic damage in multiple GVHD-targeted organs. CD4 + CD25 + Foxp3+ regulatory T cells and CD62L + CD44− naive T cells are preserved in peripheral blood of GVHD mice treated with BM-MSC-derived EVs. Microarray analysis of microRNAs in BM-MSC-derived EVs shows upregulation of miR-125a-3p and downregulation of cell proliferative processes, as identified by Gene Ontology enrichment analysis.